ENCODE cell lines, expression (Ernst 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF1 | hg19_v2_chr19_-_12997995_12998021 | -0.46 | 7.0e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_17272608 | 12.15 |
ENST00000421459.2 |
VIM |
vimentin |
chr10_+_47746929 | 11.48 |
ENST00000340243.6 ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2 AL603965.1 |
annexin A8-like 2 Protein LOC100996760 |
chr10_-_47173994 | 11.39 |
ENST00000414655.2 ENST00000545298.1 ENST00000359178.4 ENST00000358140.4 ENST00000503031.1 |
ANXA8L1 LINC00842 |
annexin A8-like 1 long intergenic non-protein coding RNA 842 |
chr1_-_151965048 | 9.26 |
ENST00000368809.1 |
S100A10 |
S100 calcium binding protein A10 |
chr17_-_1619535 | 8.48 |
ENST00000573075.1 ENST00000574306.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr2_+_173292301 | 8.27 |
ENST00000264106.6 ENST00000375221.2 ENST00000343713.4 |
ITGA6 |
integrin, alpha 6 |
chr22_+_38071615 | 8.18 |
ENST00000215909.5 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
chr17_-_1619491 | 8.11 |
ENST00000570416.1 ENST00000575626.1 ENST00000610106.1 ENST00000608198.1 ENST00000609442.1 ENST00000334146.3 ENST00000576489.1 ENST00000608245.1 ENST00000609398.1 ENST00000608913.1 ENST00000574016.1 ENST00000571091.1 ENST00000573127.1 ENST00000609990.1 ENST00000576749.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr19_-_51522955 | 7.78 |
ENST00000358789.3 |
KLK10 |
kallikrein-related peptidase 10 |
chr1_-_153508460 | 7.69 |
ENST00000462776.2 |
S100A6 |
S100 calcium binding protein A6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 7.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.9 | 6.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 5.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 3.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.4 | 3.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 2.9 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 2.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 2.9 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 2.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 2.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 2.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 2.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 2.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 1.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.1 | GO:0038025 | glycoprotein transporter activity(GO:0034437) reelin receptor activity(GO:0038025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 2.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 1.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 11.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 4.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 4.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 2.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 2.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 2.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.9 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 2.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.6 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.9 | GO:0042629 | mast cell granule(GO:0042629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 44.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 36.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 33.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 27.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 27.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 25.9 | PID ATM PATHWAY | ATM pathway |
1.1 | 24.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 24.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.9 | 22.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 20.0 | PID IFNG PATHWAY | IFN-gamma pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.0 | 3.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 3.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.5 | 1.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.0 | 1.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 1.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 32.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 30.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 22.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 18.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 17.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 9.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 8.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 8.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 7.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 6.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 45.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 40.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 37.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.0 | 29.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.7 | 26.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 25.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 25.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 23.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.4 | 23.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 22.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 1.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.8 | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 1.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.4 | 1.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 1.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 1.0 | GO:0021678 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.8 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 3.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 3.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 1.8 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.4 | 1.5 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.3 | 1.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 1.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 1.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 1.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.2 | 1.0 | GO:0002254 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 23.9 | GO:0035878 | nail development(GO:0035878) |
0.4 | 17.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.7 | 15.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 11.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.0 | 11.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 11.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.7 | 10.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 9.7 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.3 | 9.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
1.1 | 8.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 1.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 262.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 57.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 44.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 38.4 | GO:0005667 | transcription factor complex(GO:0005667) |
1.5 | 35.1 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 34.1 | GO:0016605 | PML body(GO:0016605) |
1.3 | 27.9 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 26.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 25.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 24.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 5.8 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 4.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 3.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 2.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 2.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 2.7 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 2.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 2.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 2.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.9 | 2.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.3 | 2.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 42.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 33.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 30.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.3 | 30.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.1 | 27.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.5 | 26.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
3.9 | 23.4 | GO:0030421 | defecation(GO:0030421) |
1.4 | 22.8 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
1.2 | 22.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
1.6 | 20.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 78.5 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.4 | 74.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 65.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 60.8 | GO:0003677 | DNA binding(GO:0003677) |
2.6 | 36.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 33.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 30.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 26.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 26.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.0 | 24.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 20.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 19.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.5 | 19.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 19.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 16.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 15.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.7 | 13.3 | GO:0044548 | S100 protein binding(GO:0044548) |
2.0 | 12.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 12.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.6 | 10.7 | GO:0038191 | neuropilin binding(GO:0038191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 21.5 | GO:0031012 | extracellular matrix(GO:0031012) |
7.1 | 21.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.2 | 20.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.8 | 17.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 16.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 15.6 | GO:0005615 | extracellular space(GO:0005615) |
1.4 | 11.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 10.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 9.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 9.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 1.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 13.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 12.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.4 | 11.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.5 | 8.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 8.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 7.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 5.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 5.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 5.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 3.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 2.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 2.1 | GO:0030879 | mammary gland development(GO:0030879) |
0.5 | 1.6 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.2 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 1.3 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 1.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 1.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |